FDA: Testosterone Products Must Warn About Clot Risk

iStock/Thinkstock(NEW YORK) -- The U.S. Food and Drug Administration is calling for manufacturers to include a general warning in the drug labeling of all approved testosterone products, drawing attention to the risk of vein blood clots. The potential for ... Read Full Story